BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20062996)

  • 21. Silent thyroiditis associated with etanercept in rheumatoid arthritis.
    Andrés E; Limbach FX; Goichot B; Sibilia J
    Ann Rheum Dis; 2002 Jun; 61(6):565. PubMed ID: 12006340
    [No Abstract]   [Full Text] [Related]  

  • 22. Etanercept-induced necrotizing crescentic glomerulonephritis in two patients with rheumatoid arthritis.
    Kaneko K; Nanki T; Hosoya T; Mizoguchi F; Miyasaka N
    Mod Rheumatol; 2010 Dec; 20(6):632-6. PubMed ID: 20617355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Etanercept].
    Takeuchi T; Amano K
    Nihon Rinsho; 2002 Dec; 60(12):2390-6. PubMed ID: 12510367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A case of pulmonary nontuberculous mycobacteriosis aggravated during treatment with etanercept for rheumatoid arthritis].
    Esaki T; Sugimoto M; Mori S; Yamashita A; Matsumoto M; Kohrogi H
    Nihon Kokyuki Gakkai Zasshi; 2010 Apr; 48(4):312-6. PubMed ID: 20432974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Etanercept treatment in rheumatoid arthritis patients with chronic kidney failure on predialysis.
    Cho SK; Sung YK; Park S; Bae SC
    Rheumatol Int; 2010 Sep; 30(11):1519-22. PubMed ID: 19705121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic sarcoidosis induced by etanercept: first Brazilian case report.
    Unterstell N; Bressan AL; Serpa LA; Fonseca e Castro PP; Gripp AC
    An Bras Dermatol; 2013; 88(6 Suppl 1):197-9. PubMed ID: 24346918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Minimal change nephrotic syndrome developing in a rheumatoid arthritis patient under etanercept treatment].
    Takeuchi T; Takegawa M; Ito Y; Kishi F; Miyamoto M; Minakata T
    Nihon Rinsho Meneki Gakkai Kaishi; 2008 Jun; 31(3):178-82. PubMed ID: 18587229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-TNF-alpha-induced systemic lupus syndrome.
    Debandt M; Vittecoq O; Descamps V; Le Loët X; Meyer O
    Clin Rheumatol; 2003 Feb; 22(1):56-61. PubMed ID: 12605321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Difference in the risk of serious infections in patients with rheumatoid arthritis treated with adalimumab, infliximab and etanercept: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry.
    van Dartel SA; Fransen J; Kievit W; Flendrie M; den Broeder AA; Visser H; Hartkamp A; van de Laar MA; van Riel PL
    Ann Rheum Dis; 2013 Jun; 72(6):895-900. PubMed ID: 22887849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Demyelinating disease and cutaneous lymphocitic vasculitis after etanercept therapy in a patient with rheumatoid arthritis.
    Clemente RE
    Scand J Rheumatol; 2007; 36(3):244-5; author reply 245. PubMed ID: 17657687
    [No Abstract]   [Full Text] [Related]  

  • 31. Development of type 1 diabetes in a patient treated with anti-TNF-alpha therapy for active rheumatoid arthritis.
    Tack CJ; Kleijwegt FS; Van Riel PL; Roep BO
    Diabetologia; 2009 Jul; 52(7):1442-4. PubMed ID: 19440690
    [No Abstract]   [Full Text] [Related]  

  • 32. The yin and yang of tumor necrosis factor inhibitors.
    Calabrese L
    Cleve Clin J Med; 2006 Mar; 73(3):251-6. PubMed ID: 16548447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful treatment with very low-dose etanercept in a patient with etanercept-induced liver dysfunction.
    Iwamoto M; Minota S
    Rheumatol Int; 2011 Apr; 31(4):561-2. PubMed ID: 20349067
    [No Abstract]   [Full Text] [Related]  

  • 34. Etanercept-associated pulmonary granulomatous inflammation in patients with rheumatoid arthritis.
    Ognenovski VM; Ojo TC; Fox DA
    J Rheumatol; 2008 Nov; 35(11):2279-82. PubMed ID: 19004058
    [No Abstract]   [Full Text] [Related]  

  • 35. [A case of cavitating pneumococcal pneumonia developed during the treatment with etanercept for rheumatoid arthritis].
    Kida Y; Harada Y; Tachikawa R; Hata A; Kaji R; Takeshima Y; Hayashi M; Nishimura T; Tomii K; Katakami N; Ishihara K
    Nihon Kokyuki Gakkai Zasshi; 2009 Apr; 47(4):320-5. PubMed ID: 19455963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of rheumatoid arthritis with etanercept.
    Genovese MC; Kremer JM
    Rheum Dis Clin North Am; 2004 May; 30(2):311-28, vi-vii. PubMed ID: 15172043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Adverse events in rheumatoid arthritis patient with etanercept therapy: the appearance of osteomalacia].
    D'Amore M; Minenna G; D'Amore S
    Recenti Prog Med; 2005 Nov; 96(11):552-5. PubMed ID: 16499162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pneumonia, pneumocystis pneumonia].
    Koike R; Harigai M
    Nihon Rinsho; 2007 Jul; 65(7):1314-20. PubMed ID: 17642249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Etanercept-induced pleuropericardial lupus-like syndrome.
    Porfyridis I; Kalomenidis I; Psallidas I; Stratakos G; Roussos C; Vassilakopoulos T; Stathopoulos GT
    Eur Respir J; 2009 Apr; 33(4):939-41. PubMed ID: 19336597
    [No Abstract]   [Full Text] [Related]  

  • 40. Developing of granulomatous thyroiditis during etanercept therapy.
    Cañas CA; Tobón GJ; Arango LG; Guarín N
    Clin Rheumatol; 2009 Jun; 28 Suppl 1():S17-9. PubMed ID: 19043773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.